Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Cellular proteins involved in DNA repair pathways" is not a single molecule or receptor but rather refers collectively to a large and diverse set of **proteins** that detect, signal, and correct various forms of **DNA damage** within the cell. These include enzymes such as nucleases (e.g., XPF), helicases (e.g., WRN), polymerases (e.g., Polζ), scaffold/adaptor proteins (e.g., SLX4), chromatin remodelers, and regulatory kinases. Key examples are **BRCA1**, **BRCA2**, **RAD51**, **PARP1**, components of the MRN complex (**MRE11-RAD50-NBS1**), RPA subunits (**RPA1/2/3**), FANCI/FANCD2 from the Fanconi anemia pathway, among many others[1][3][5]. These proteins function across several distinct but sometimes overlapping pathways including base excision repair, nucleotide excision repair, mismatch repair, homologous recombination repair, non-homologous end joining and direct reversal mechanisms[6][7]. Defects or mutations in these genes/proteins are strongly associated with increased risk for cancer development due to loss of genome integrity. Because this entry refers broadly to an entire functional class rather than a specific molecular entity or druggable target—and includes multiple unrelated families—it is considered *incorrect* as an individual therapeutic target according to standard nomenclature conventions. For structured data purposes it should be replaced by entries for each specific protein/gene involved in particular DNA repair processes. --- If you need information on any *specific* cellular protein within these pathways—such as "Poly(ADP-ribose) polymerase 1" (*PARP1*) or "Breast cancer type 2 susceptibility protein" (*BRCA2*)—please specify which one.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular protein involved in DNA repair pathway.